Association of efficacy of long acting beta 2-agonist (LABA) and single nucleotide polymorphisms (SNP) of beta 2-adrenergic receptors in elderly patients with COPD
Not Applicable
Not yet recruiting
- Conditions
- COPD
- Registration Number
- JPRN-UMIN000002629
- Lead Sponsor
- Tokyo Metropolitan Geriatric Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included age younger than 65, dementia and any previously usage of inhaled medications such as beta 2-agonists, anti-cholinergics or corticosteroids, patched beta 2--agonist, or systemic corticosteroids. Patients with dermatological disorders, severe heart diseases, uncontrolled hypertension or other diseases for whom patch preparations or treatments with beta 2-agonists was considered inappropriate were also excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method